DEA Adds Benzimidazole-Opioids to Schedule I Drug List
The Drug Enforcement Administration is permanently placing the synthetic benzimidazole-opioids etodesnitazene, n-pyrrolidino etonitazene and protonitazene in Schedule I of the Controlled Substances Act, it said in a final order released April 10. The substances had already been temporarily listed in…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Schedule I since 2022 (see 2204110029). The final order is set to take effect April 11.